Inotiv, Inc. to Participate in Three Investor Conferences in September 2025

Core Viewpoint - Inotiv, Inc. is actively participating in several upcoming investment conferences, showcasing its commitment to engaging with investors and promoting its services in the drug discovery and development sector [1][2]. Company Overview - Inotiv, Inc. is a leading contract research organization that specializes in nonclinical and analytical drug discovery and development services, as well as research models and related products [3]. - The company focuses on enhancing efficiency, improving data quality, and reducing costs associated with bringing new drugs and medical devices to market [3]. - Inotiv aims to support researchers in achieving their research and development objectives while contributing to a healthier and safer world [3]. Conference Participation - Inotiv's management, including President and CEO Robert Leasure Jr. and CFO Beth Taylor, will participate in the following conferences: - Baird Global Healthcare Conference on September 9, 2025, at 12:50 PM Eastern Time [2]. - H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025, at 12:30 PM Eastern Time [2]. - Lake Street Capital Markets 9th Annual Best Ideas Growth Conference on September 11, 2025, with a focus on 1-on-1 institutional investor meetings [2].